Clinical Decision Support (CDS): Meeting the Meaningful Use Measures Massachusetts Medicaid EHR Incentive Program May 14, 2019 & May 20, 2019.

Slides:



Advertisements
Similar presentations
Meeting Stage 1 Meaningful Use Criterion Carlos A. Leyva, Esq. Digital Business Law Group, P.A.
Advertisements

TWS July2011 Stimulation Part 2. TWS July 2011 Objective: Implement drug formulary checks. Measure: The EP has enabled this functionality and has access.
Slide 1 Regional Care Collaborative March 26, 2015.
GOVERNMENT EHR FUNDING: MEANINGFUL USE STAGE 2 UPDATE October 25, 2012 Jonathan Krasner Healthcare IT Consultant BEI
CMS Proposals for Quality Reporting Programs Under the 2015 Medicare Physician Fee Schedule Proposed Rule PQRS, EHR Incentive Program, Physician Compare,
MEANINGFUL USE UPDATE 2014 Mark Huang, M.D. Chief Medical Information Officer Rehabilitation Institute of Chicago Associate Professor Department of PM.
Medicare & Medicaid EHR Incentive Programs
A First Look at Meaningful Use Stage 2 John D. Halamka MD.
Meaningful Use Stage 2 Esthee Van Staden September 2014.
Meaningful Use Measures. Reporting Time Periods Reporting Period for 1 st year of MU (Stage 1) 90 consecutive days within the calendar year Reporting.
2015 User Conference Surviving an MU Audit April 24, :15 pm Guest Speaker: Grace Bell NYC REACH, New York City Regional Extension Center Co-presenter:
The Auditing Process: Lessons Learned Florida’s Medicaid EHR Incentive Program July 23, 2015.
Medicaid EHR Incentive Program For Eligible Professionals Overview of the Proposed 2015 Modification Rule Kim Davis-Allen Outreach Coordinator
Affordable Healthcare IT Solutions. MU RX Compliance with Meaningful Use Stage 2.
Implementation days 10 Days Onsite Training Additional Hardware Automated Workflow Paperless Environment MD with PC Tablet / iPad Workflow Analysis.
1 Meaningful Use Stage 2 The Value of Performance Benchmarking.
Medicare & Medicaid EHR Incentive Programs Jason McNamara Technical Director for Health IT.
Medicare & Medicaid EHR Incentive Programs Stage 2 Final Rule Travis Broome HIT Standards Committee
Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage.
CMS Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs Final Rule Overview 1 Robert Anthony.
Configuring axiUm for Meaningful Use
New Jersey Institute of Technology Enterprise Development Center (EDC) 211 Warren Street, Newark, NJ Phone: Fax:
CDSS, queries and statistics FLL July 2011 Claudia Wente-Waedlich.
Medicaid EHR Incentive Program Updates eHealth Services and Support September 24, 2014 Today’s presenter: Nicole Bennett, Provider Enrollment and Verification.
The Impact of Proposed Meaningful Use Modifications for June 23, 2015 Today’s presenters: Al Wroblewski, Client Services Relationship Manager.
Final Rule Regarding EHR Certification Flexibility for 2014 Today’s presenters: Al Wroblewski, Client Services Relationship Manager Thomas Bennett, Client.
MAPIR 5.7 Walk-Through Vermont Medicaid Electronic Health Record (EHR) Incentive Program May 25, 2016.
Meaningful Use Update 2015: How Does It Impact Family Medicine? Ryan Mullins, MD, CPE, CPHQ, CPHIT.
Stage 2 Beyond the First Year on MU in 2014 Presenters: Randy Marsden – Chief Client Officer Leo Vilenskiy – Senior Customer Support Representative Rebecca.
CMS Final Rule: Stage 3 Meaningful Use and Modifications to MU for November 3, 2015 Today’s presenters: Thomas Bennett, Client Services Relationship.
Modified Stage 2 Meaningful Use Program Year 2015: Attestation 101 Massachusetts Medicaid EHR Incentive Payment Program July 5, 2016 Today’s presenter:
Psychiatric Clinical Nurse Specialists: Adopt, Implement, Upgrade (AIU) Massachusetts Medicaid EHR Incentive Program August 3, 2016 Today’s presenter:
AUDITS….. MEANINGFUL USE AND HIPAA COMPLIANCE (OCR) MARK NORRIS MEDICAL RECORDS SERVICES
Modified Stage 2 Meaningful Use: Objective #8 – Patient Electronic Access Massachusetts Medicaid EHR Incentive Payment Program July 19, 2016 Today’s presenter:
The Value of Performance Benchmarking
Meaningful Use Audit Webinar Series March 25, 2015: An Overview of the Meaningful Use Audit Process 1 in 10 providers will receive a MU audit letter April.
Meaningful Use Objectives Overview Massachusetts Medicaid EHR Incentive Program September 16, 2016 Today’s presenters: Brendan Gallagher Thomas.
Modified Stage 2 Meaningful Use: Objective #9 – Secure Electronic Messaging Massachusetts Medicaid EHR Incentive Payment Program July 19, 2016 Today’s.
Advancing Care Information
EHR Incentive Program 2017 Program Requirements
Meaningful Use Audit Webinar Series March 25, 2015: An Overview of the Meaningful Use Audit Process 1 in 10 providers will receive a MU audit letter April.
Florida’s Medicaid EHR Incentive Program
Psychiatric Clinical Nurse Specialists: Patient Volume Threshold (PVT) Massachusetts Medicaid EHR Incentive Program August 2, 2016 Today’s presenter:
Stage 3 and ACI’s Relationship to Medicaid MU Massachusetts Medicaid EHR Incentive Program September 19 & 20, 2017 Today’s presenters: Brendan Gallagher.
Modified Stage 2 Meaningful Use: Objective #7– Medication Reconciliation Massachusetts Medicaid EHR Incentive Payment Program July 14, 2016 Today’s presenter:
Modified Stage 2 Meaningful Use: Objective #4 – ePrescribing (eRx) Massachusetts Medicaid EHR Incentive Payment Program July 12, 2016 Today’s presenter:
Interoperability and Patient Engagement: Health Information Exchange (HIE), Secure Messaging, and Patient Portals for Modified Stage 2 September.
Introduction to the Quality Payment Program & MIPS
Modified Stage 2 Meaningful Use: Objective #2 – Clinical Decision Support Massachusetts Medicaid EHR Incentive Payment Program July 7, 2016 Today’s presenter:
EHR Incentive Program 2017 Program Requirements
Modified Stage 2 Meaningful Use: Objective #1 – Protect Electronic Health Information July 5, 2016 Today’s presenter: Al Wroblewski, PCMH CCE, Client.
Meaningful Use Overview for Program Year 2017 Massachusetts Medicaid EHR Incentive Program October 23 & 24, 2017 Presenters: Elisabeth Renczkowski,
Praxis EMR Training Seminar
MediSYS EHR About Meaningful Use
Meaningful Use Boot Camp Webinar Massachusetts Medicaid EHR Incentive Program September 18 & 19, 2018 Today’s presenters: Brendan Gallagher and.
Modified Stage 2 Meaningful Use Program Year 2015: Attestation 101 Massachusetts Medicaid EHR Incentive Payment Program July 5, 2016 Today’s presenter:
EHR Incentive Program 2018 Program Requirements
Modified Stage 2 Meaningful Use: Objective #6 – Patient Specific Education Massachusetts Medicaid EHR Incentive Payment Program July 14, 2016 Today’s.
Insights into the Validation Process Massachusetts Medicaid EHR Incentive Program September 12, 2016 Today’s presenter: Nicole Bennett.
2017 Supporting Documentation Requirements Massachusetts Medicaid EHR Incentive Program September 19 & 20, 2017 Good Morning Everyone My name is.
2017 Modified Stage 2 Meaningful Use Objectives Overview Massachusetts Medicaid EHR Incentive Program September 19 & 20, 2017 September 19,
Modified Stage 2 Meaningful Use: Objective #1 – Protect Electronic Health Information July 5, 2016 Today’s presenter: Al Wroblewski, PCMH CCE, Client.
An Overview of Meaningful Use Proposed Rules in 2015
Death, Taxes and Meaningful Use Audits
Modified Stage 2 Meaningful Use: Objective #10 – Public Health Reporting Massachusetts Medicaid EHR Incentive Payment Program July 21, 2016 Today’s presenter:
Modified Stage 2 Meaningful Use: Objective #5 – Health Information Exchange (Summary of Care) Massachusetts Medicaid EHR Incentive Payment Program July.
Health Information Exchange (HIE): Meeting the Measures for Stage 3 Massachusetts Medicaid EHR Incentive Program May 13, 2019 & May 21, 2019.
[Practice Name Here] [Tax ID# Here]
Meaningful Use Information Session June 18, 2019
Meaningful Use Information Session September 19, 2019
Presentation transcript:

Clinical Decision Support (CDS): Meeting the Meaningful Use Measures Massachusetts Medicaid EHR Incentive Program May 14, 2019 & May 20, 2019 Today’s presenters: Margaret Lellman Thomas Bennett

Disclaimer This presentation was current at the time it was presented, published or uploaded onto the web. This presentation was prepared as a service to the public and is not intended to grant rights or impose obligations. This presentation may contain references or links to statutes, regulations, or other policy materials. The information provided is only intended to be a general summary. It is not intended to take the place of either the written law or regulations. We encourage attendees to review the specific statutes, regulations, and other interpretive materials for a full and accurate statement of their contents.

Reminders: 2015 Edition CEHRT 2015 Edition CEHRT functionality is required to meet Stage 3 requirements The 2015 Edition CEHRT must be installed and used for the entirety of the EP’s selected 90-day EHR reporting period If your EPs have not yet upgraded, start the process ASAP If EPs don’t upgrade to the 2015 CEHRT Edition before October 3rd, they won’t be able to attest to Program Year 2019

The attestation deadline for Program Year 2019 is March 31, 2020 Reminder The attestation deadline for Program Year 2019 is March 31, 2020

Agenda Purpose of This Webinar MU Objective: Clinical Decision Support (CDS) – Stage 3 Strategies and Tips for Success Common Issues MU Supporting Documentation Screenshots of CDS Interventions CDS Explanation Letter Global CDS Letter Vendor Letter/Audit Log

Purpose of this Webinar We want to help you: Meet the measures for MU Objective 3, Clinical Decision Support (CDS) Save time by getting it right the first time and avoid application recycling Ensure accuracy of your MU supporting documentation At the end of this session, attendees will take away: Why Clinical Decision Support (CDS) is important Options and strategies for meeting the measures while minimizing potential issues Examples of approved CDS supporting documentation Common EHR vendors

MU Objective: Clinical Decision Support (CDS) – Stage 3 Use clinical decision support (CDS) to improve performance on high-priority health conditions Measures Implement 5 CDS interventions related to 4 or more CQMs for the entire EHR reporting period Enable and implement drug-drug & drug-allergy interaction checks for the entire EHR reporting period Exclusion for Measure 2 Any EP who writes fewer than 100 medication orders during EHR reporting period Exchange may occur before, during or after the EHR reporting period but must occur within the calendar year Only patients whose records are maintained using CEHRT must be included in the denominator for transitions of care

Strategies and Tips for Success Select and report CQMs that align with CDS interventions enabled in the EHR EPs who have previously attested to MU must report on a 365-day reporting period for CQMs EPs must report on at least 6 CQMs in MAPIR, at least 4 of which must relate to the EP’s selected CDSRs If there are limited CQMs applicable to an EP's scope of practice, the EP should implement CDS interventions that will drive improvements in the delivery of care for the high-priority health conditions relevant to their specialty and patient population Drug-drug and drug-allergy interaction alerts are separate from the 5 CDS interventions and do not count toward the 5 required for Measure 1

Strategies and Tips for Success, continued Have 1 vendor letter confirming enabled dates for both the 5 selected CDS alerts and the Drug-Drug/Drug-Allergy checks Confirm EP’s total number of medication orders during the MU reporting period is 100+ EP can claim exclusion for Measure 2 (Drug-Drug and Drug-Allergy checks) if fewer than 100

Common Issues Practice defines CDS too narrowly Not just alerts Not just for physicians CEHRT does not have relevant CDS interventions implemented Alert fatigue; alerts ignored and not recorded After there is an alert, notification, or explicit care suggestion, follow-through implementation is lacking Obtaining proper supporting documentation CEHRT functionality Screenshots missing profile info and/or CDS enabled date Audit logs/reports tracking CDS intervention history unavailable EHR vendor engagement and support

Entering Data Into MAPIR MAPIR Application Attestation Tab > Meaningful Use > Objective 3: Clinical Decision Support

CDS: MU Supporting Documentation for Stage 3 Upload Supporting Documentation Measure 1 EHR-generated screenshots of 5 CDS interventions dated within EHR reporting period and identifying both EP and organization Documentation showing that CDS interventions were enabled for the entire EHR reporting period If screenshots don’t display enabled dates, submit either CEHRT audit logs with enabled dates, or vendor letter confirming enabled dates and that EPs are unable to deactivate interventions Documentation showing interventions relate to 4 or more CQMs related to the scope of practice, OR a letter from EP’s Supervisor or Medical Director explaining CDS’s relationship to patient population and high priority conditions * For global CDS implementations, you must also submit: Screenshot with practice name and enabled date Global CDS Letter on letterhead and signed by Medical Director confirming relevance to EP and including a list of all EPs using the CDS Measure 2 Documentation from CEHRT identifying both EP & organization showing drug-drug and drug-allergy interaction checks were enabled for the entire reporting period

Example 1: Screenshot of alerts enabled in CEHRT Screenshot displays all relevant data elements to prove MU compliance: Vendor Name, EP Name, enabled CDSRs and Date.

Example 2: Screenshot of alerts enabled in CEHRT EHR-generated screenshot of interventions identifying the EP, organization, enabled alerts and dates

Example 3: MU Dashboard showing enabled alerts MU Dashboard displays EP’s name, attesting organization, reporting period, and enabled interventions dated with CQMs.

Sample Template: Letter of Explanation CDS interventions must relate to 4 or more CQMs related to the EP’s scope of practice if reported CQMs do not relate to enabled CDSRs, submit a letter from EP’s Supervisor or Medical Director explaining CDSR’s relationship to patient population and high priority conditions Global CDS Letter on letterhead and signed by Medical Director confirming relevance to EP and including a list of all EPs using CDS Note: This is a fictional example

Example: Audit log showing alerts were enabled If screenshots don’t display enabled dates, submit either CEHRT audit logs with enabled dates, or a vendor letter confirming enabled dates and that EPs are unable to deactivate interventions

Example: Vendor Letter confirming dates alerts were enabled If screenshots don’t display enabled dates, submit either CEHRT audit logs with enabled dates, or a vendor letter confirming enabled dates and that EPs are unable to deactivate interventions

Example: Drug-Drug & Drug-Allergy Documentation from CEHRT identifying both EP & organization showing drug-drug & drug-allergy interaction checks were enabled for the entire reporting period Typically a screenshot showing drug-drug & drug-allergy interaction checks were enabled for the entire reporting period, or a vendor letter confirming the enabled dates

Questions Questions?

Contact Us Thomas Bennett Margaret Lellman Client Services Relationship Manager tbennett@masstech.org (508) 870-0312 ext. 403 Margaret Lellman Technical Assistance Specialist lellman@masstech.org (508) 870-0312 ext. 370